Lynette M Sholl

Lynette M Sholl

UNVERIFIED PROFILE

Are you Lynette M Sholl?   Register this Author

Register author
Lynette M Sholl

Lynette M Sholl

Publications by authors named "Lynette M Sholl"

Are you Lynette M Sholl?   Register this Author

100Publications

2942Reads

48Profile Views

Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA.

Lung Cancer 2019 Aug 5;134:96-99. Epub 2019 Jun 5.

Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, 360 Longwood Avenue, Boston, MA, 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.06.004DOI Listing
August 2019

Imaging of Precision Therapy for Lung Cancer: Current State of the Art.

Radiology 2019 Aug 6:190173. Epub 2019 Aug 6.

From the Departments of Imaging (H.P., M.N.) and Medical Oncology (M.M.A.), Dana-Farber Cancer Institute, and Departments of Radiology (H.P., H.H., M.N.), Pathology (L.M.S.), and Medicine (M.M.A.), Brigham and Women's Hospital, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2019190173DOI Listing
August 2019

Characteristics of mismatch repair deficiency in sarcomas.

Mod Pathol 2019 Jul 14;32(7):977-987. Epub 2019 Feb 14.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41379-019-0202-3
Publisher Site
http://dx.doi.org/10.1038/s41379-019-0202-3DOI Listing
July 2019

Metastatic Basal Cell Carcinoma.

Am J Clin Pathol 2019 Jul 29. Epub 2019 Jul 29.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcp/aqz089DOI Listing
July 2019

Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma.

Mod Pathol 2019 Jun 9;32(6):830-843. Epub 2019 Jan 9.

Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41379-018-0200-x
Publisher Site
http://dx.doi.org/10.1038/s41379-018-0200-xDOI Listing
June 2019

Detection of ERBB2 Amplification by Next-Generation Sequencing Predicts HER2 Expression in Colorectal Carcinoma.

Am J Clin Pathol 2019 Jun;152(1):97-108

Department of Pathology, Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcp/aqz031DOI Listing
June 2019

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.

J Thorac Oncol 2019 Jun 20. Epub 2019 Jun 20.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.06.009DOI Listing
June 2019

Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.

Arch Pathol Lab Med 2018 12 30;142(12):1537-1548. Epub 2018 Apr 30.

From the Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill (Drs Funkhouser Jr and Banks); Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina (Drs Funkhouser Jr, Hayes, Nikolaishvilli-Feinberg, and Grilley-Olson; Messrs Moore and Jo; and Ms Eeva); the Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina (Drs Hayes and Grilley-Olson); the Department of Computer Sciences, University of Wisconsin, Madison (Mr Funkhouser III); the Department of Biostatistics, UNC School of Public Health, Chapel Hill, North Carolina (Dr Fine); Medical Affairs, Ventana Medical Systems, Tucson, Arizona (Dr Banks); Unit of Pathology, Scientific Institute for Research and Health Care, San Giovanni Rotondo, Italy (Dr Graziano); the Department of Pathology, VA Medical Center, Durham, North Carolina (Dr Boswell); the Department of Medical Biosciences, Pathology, Umeå University Hospital, Umeå, Sweden (Dr Elmberger); the Department of Pathology, Kaiser-Permanente Hospital, Santa Clara, California (Dr Raparia); the Department of Pathology, Piedmont Medical Center, Rock Hill, South Carolina (Dr Hart); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl); the Department of Pathology, Suburban Hospital, Bethesda, Maryland (Dr Nolan); the Department of Pathology, Mayo Clinic, Rochester, Minnesota (Dr Fritchie); the Department of Pathology, VA Medical Center, Dayton, Ohio (Dr Pouagare); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Rex Hospital, Raleigh, North Carolina (Dr Volmar); the Department of Pathology, Medical College of Georgia, Augusta (Drs Biddinger and Kleven); the Department of Pathology, Flagstaff Medical Center, Flagstaff, Arizona (Dr Papez); the Department of Pathology, VA Medical Center, Charleston, South Carolina (Dr Spencer); the Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Mino-Kenudson and Hariri); and the Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Driver and Cagle). Dr Allen is currently located at the Department of Pathology at University of Mississippi Medical Center, Jackson.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0481-OADOI Listing
December 2018

Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma.

Mod Pathol 2018 12 28;31(12):1882-1890. Epub 2018 Jun 28.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0091-xDOI Listing
December 2018

Diagnostic and Predictive Immunohistochemistry for Non-Small Cell Lung Carcinomas.

Adv Anat Pathol 2018 Nov;25(6):374-386

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000206DOI Listing
November 2018

Recognizing the Challenges of Oncogene Fusion Detection: A Critical Step toward Optimal Selection of Lung Cancer Patients for Targeted Therapies.

Authors:
Lynette M Sholl

J Thorac Oncol 2018 10;13(10):1433-1435

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183093
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.08.002DOI Listing
October 2018

Reply to Petals and thorns in programmed death-ligand 1 testing: Is all non-small cell lung cancer diagnostic material suitable?

Cancer Cytopathol 2018 09 21;126(9):819-820. Epub 2018 Sep 21.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncy.22032
Publisher Site
http://dx.doi.org/10.1002/cncy.22032DOI Listing
September 2018

An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus Trametinib.

J Thorac Oncol 2018 08 6;13(8):e131-e133. Epub 2018 Apr 6.

Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.03.026DOI Listing
August 2018

Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping.

Lung Cancer 2018 08 25;122:72-75. Epub 2018 May 25.

Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.05.024DOI Listing
August 2018

Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO).

Int J Gynecol Pathol 2018 Aug 21. Epub 2018 Aug 21.

Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (J.M.) Department of Pathology (F.D., L.M.S., E.G., N.L.) Department of Pathology, Division of Women's and Perinatal Pathology (J.M., C.P.C., M.R.N., B.E.H.), Brigham and Women's Hospital Dana-Farber Cancer Institute (E.G., L.M.), Boston, Massachusetts Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK (W.G.M.) Department of Pathology, Stanford University School of Medicine, Stanford, California (B.E.H.).

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004347-900000000-9915
Publisher Site
http://dx.doi.org/10.1097/PGP.0000000000000545DOI Listing
August 2018

Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.

Cancer Discov 2018 07 17;8(7):822-835. Epub 2018 May 17.

Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030433PMC
July 2018

Sarcoid-Like Granulomatosis of the Lung Related to Immune-Checkpoint Inhibitors: Distinct Clinical and Imaging Features of a Unique Immune-Related Adverse Event.

Cancer Immunol Res 2018 06 5;6(6):630-635. Epub 2018 Apr 5.

Departments of Medical Oncology and Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://cancerimmunolres.aacrjournals.org/lookup/doi/10.1158/
Publisher Site
http://dx.doi.org/10.1158/2326-6066.CIR-17-0715DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984707PMC
June 2018

Cytologic-histologic correlation of programmed death-ligand 1 immunohistochemistry in lung carcinomas.

Cancer Cytopathol 2018 04 5;126(4):253-263. Epub 2018 Feb 5.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.21973DOI Listing
April 2018

Genomic Characterization of Low- and High-Grade Pancreatic Mucinous Cystic Neoplasms Reveals Recurrent KRAS Alterations in "High-Risk" Lesions.

Pancreas 2017 May/Jun;46(5):665-671

From the *Department of Pathology, Brigham and Women's Hospital; †Harvard Medical School; and ‡Department of Pathology, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000805DOI Listing
March 2018

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2018 Mar 7;142(3):408-419. Epub 2017 Jul 7.

From the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Drs Thunnissen and Radonic); the Department of Pathology, The University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Gustave Roussy, Villejuif, France (Dr Adam); the Department of Pathology, University of Colorado, Aurora (Dr Aisner); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Cagle and Miller); the Department of Pathology, University of São Paulo, São Paulo, Brazil (Dr Capelozzi); the Department of Pathology, Royal Prince Alfred Hospital, Sydney, Australia (Dr Cooper); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, University Clinic Golnik, Golnik, Slovenia (Dr Kern); the Department of Pathology, INSERM U578, CHU A Michallon, Centre Léon Bérard, Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, The University Of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, St. Vincent's Pathology, Fitzroy, Australia (Ms Russell); the Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr Schneider); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Pathology, University of Toronto, University Health Network, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0106-SADOI Listing
March 2018

Implications of the tumor immune microenvironment for staging and therapeutics.

Mod Pathol 2018 02 1;31(2):214-234. Epub 2017 Dec 1.

Department of Pathology, The Johns Hopkins University SOM and Bloomberg-Kimmel Institute for Immunotherapy, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2017.156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132263PMC
February 2018

Hypersensitivity Pneumonitis A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2018 Jan 14;142(1):120-126. Epub 2017 Jun 14.

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Miller, Barrios, Cagle, and Ge); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Histopathology, Cork University Hospital, Cork, Ireland (Dr Burke); the Department of Pathology, University of São Paulo, São Paulo, Brazil (Dr Capelozzi); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Hariri, Mark, and Mino-Kenudson); the Department of Pathology, Aberdeen University School of Medicine, Aberdeen, United Kingdom (Dr Kerr); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida (Dr Khoor); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona (Drs Larsen and Smith); the Department of Pathology, National Defense Medical College, Tokorozawa, Japan (Dr Matsubara); the Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Mehrad); the Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Dr Roden); the Department of Pathology, St Vincent's Pathology, Fitzroy, Australia (Dr Russell); the Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr Schneider); and the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0138-SADOI Listing
January 2018

GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.

Mod Pathol 2017 12 4;30(12):1720-1727. Epub 2017 Aug 4.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2017.88DOI Listing
December 2017

Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.

Radiographics 2017 Sep-Oct;37(5):1371-1387

From the Departments of Radiology (M.N., H.H., N.H.R.) and Pathology (L.M.S.), Brigham and Women's Hospital and Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.2017170015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621730PMC
December 2017

Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.

Am J Surg Pathol 2017 Nov;41(11):1473-1482

*Department of Pathology, Massachusetts General Hospital ¶Department of Surgery, Massachusetts General Hospital ‡Department of Pathology, Brigham and Women's Hospital §Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School ∥Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA #Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN †Northern Institute for Cancer Research, University of Newcastle, Newcastle on Tyne, UK.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00000478-201711000-0000
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000945DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657508PMC
November 2017

Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series.

Biol Blood Marrow Transplant 2017 Oct 28;23(10):1767-1772. Epub 2017 Jun 28.

Department of Medicine, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797990PMC
October 2017

Next-generation sequencing of cytologic preparations: An analysis of quality metrics.

Cancer Cytopathol 2017 Oct 20;125(10):786-794. Epub 2017 Jul 20.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.21897DOI Listing
October 2017

Next-Generation Sequencing from Liquid Biopsies in Lung Cancer Patients: Advances in Comprehensive Biomarker Testing.

Authors:
Lynette M Sholl

J Thorac Oncol 2017 10;12(10):1464-1466

Brigham and Women's Hospital and Department of Pathology, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.08.004DOI Listing
October 2017

Genomic Analysis of Plasma Cell-Free DNA in Patients With Cancer.

JAMA Oncol 2017 06;3(6):740-741

Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts5Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.2835DOI Listing
June 2017

Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour.

Histopathology 2017 Jun 20;70(7):1138-1146. Epub 2017 Mar 20.

Department of Pathology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13176DOI Listing
June 2017

Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.

Arch Pathol Lab Med 2017 Jun 3;141(6):751-758. Epub 2017 Mar 3.

From the Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital (Drs Garcia, Minkovsky, Jia, Ligon, Sholl, Kuo, MacConaill, Lindeman, and Dong, Messrs Ducar and Gong, and Ms. Shivdasani), and the Center for Cancer Genome Discovery, Dana Farber Cancer Institute (Mr Ducar and Dr MacConaill), Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0527-OADOI Listing
June 2017

Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma.

Mod Pathol 2017 05 13;30(5):650-659. Epub 2017 Jan 13.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2016.239DOI Listing
May 2017

EGFR L858M/L861Q cis Mutations Confer Selective Sensitivity to Afatinib.

J Thorac Oncol 2017 05 11;12(5):884-889. Epub 2017 Jan 11.

Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.01.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558893PMC
May 2017

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Thyroid Carcinoma.

Arch Pathol Lab Med 2017 04 28;141(4):559-563. Epub 2016 Sep 28.

From the Department of Pathology, University of Pittsburgh Medical Center, Presbyterian Hospital, Pittsburgh, Pennsylvania (Dr Chiosea); the Department of Pathology, University Health Network, Toronto, Ontario, Canada (Dr Asa); the Department of Pathology, Jefferson Hospital, Allegheny Health Network, Jefferson Hills, Pennsylvania (Dr Berman); the Department of Surgery, Division of Endocrine Surgery (Dr Carty), and Department of Pathology (Drs Nikiforov and Seethala), University of Pittsburgh, Pittsburgh, Pennsylvania; Cancer Registrar at North Kansas City Hospital, North Kansas City, Missouri (Ms Currence); the Division of Endocrinology and Metabolism, New York University Langone Medical Center, Tisch Hospital, New York (Dr Hodak); the Department of Pathology, Medical University of South Carolina, Charleston (Dr Richardson); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl); the Department of Pathology, Southern California Permanente Medical Group, Woodland Hills, California (Dr Thompson); the Department of Pathology and Laboratory Medicine, Beth Israel Medical Center, St. Luke's and Roosevelt Hospitals, New York, New York (Dr Wenig); and the Department of Internal Medicine, Comprehensive Cancer Center, University of Michigan, Ann Arbor (Dr Worden).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0326-CPDOI Listing
April 2017

Molecular Analysis of Genetic Markers for Non-Hodgkin Lymphomas.

Curr Protoc Hum Genet 2017 04 6;93:10.14.1-10.14.29. Epub 2017 Apr 6.

Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cphg.37DOI Listing
April 2017

Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome.

Int J Gynecol Pathol 2017 Mar;36(2):115-127

Departments of Pathology (J.C.W., J.L.H., C.P.C, L.M.S., B.E.H.) Gynecologic Oncology (M.C.M., C.M.F., R.S.B., N.S.H.), Brigham And Women's Hospital Department of Medical Oncology (S.S., M.B.Y., A.C.), Dana-Farber Cancer Institute, Boston, MA Department of Pathology (E.J.Y.), Stanford University Medical Center, Palo Alto, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000312DOI Listing
March 2017

Successful Management of a Patient with Malignant Thyroid Teratoma.

Thyroid 2017 01 28;27(1):125-128. Epub 2016 Nov 28.

4 Department of Otolaryngology, Brigham and Women's Hospital , Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0201DOI Listing
January 2017

Radiation-associated neoplasia: clinical, pathological and genomic correlates.

Histopathology 2017 Jan;70(1):70-80

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13069DOI Listing
January 2017

Molecular Analysis of Gene Rearrangements and Mutations in Acute Leukemias and Myeloid Neoplasms.

Curr Protoc Hum Genet 2017 01 11;92:10.4.1-10.4.49. Epub 2017 Jan 11.

Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cphg.31DOI Listing
January 2017

'Inflammatory myofibroblastic tumour'-like dedifferentiation of anaplastic lymphoma kinase-rearranged lung adenocarcinoma.

Histopathology 2016 Sep 27;69(3):510-5. Epub 2016 Apr 27.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12952DOI Listing
September 2016

The Molecular Pathology of Lung Cancer.

Authors:
Lynette M Sholl

Surg Pathol Clin 2016 Sep;9(3):353-78

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.path.2016.04.003DOI Listing
September 2016

Preface.

Authors:
Lynette M Sholl

Surg Pathol Clin 2016 Sep;9(3):ix-x

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.path.2016.06.001DOI Listing
September 2016

Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2016 Aug 19;140(8):825-9. Epub 2016 May 19.

From the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Pathology, University of Colorado Cancer Center, Denver (Dr Aisner); the Department of Pathology, The University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell Medical College, New York, New York, and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil (Dr Capelozzi); the Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, Aberdeen University Medical School and Aberdeen Royal Infirmary, Foresterhill, Aberdeen, Scotland, United Kingdom (Dr Kerr); the Department of Biopathology, Centre Léon Bérard, Lyon, France, and J Fourier University-INSERM U 823-Institut A Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, VU Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Pathology, University Health Network/Princess Margaret Cancer Centre and University of Toronto, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0163-SADOI Listing
August 2016

Distinctive Patterns of CTNNB1 (β-Catenin) Alterations in Salivary Gland Basal Cell Adenoma and Basal Cell Adenocarcinoma.

Am J Surg Pathol 2016 08;40(8):1143-50

*Department of Pathology †Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000669DOI Listing
August 2016

Clinical and Molecular Characteristics of NF1-Mutant Lung Cancer.

Clin Cancer Res 2016 07 9;22(13):3148-56. Epub 2016 Feb 9.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/clincanres/22/
Web Search
http://clincancerres.aacrjournals.org/content/clincanres/ear
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-15-2377DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129179PMC
July 2016

Unusual Mismatch Repair Immunohistochemical Patterns in Endometrial Carcinoma.

Am J Surg Pathol 2016 07;40(7):909-16

Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000663DOI Listing
July 2016

Template for Reporting Results of Biomarker Testing of Specimens From Patients With Melanoma.

Arch Pathol Lab Med 2016 Apr 4;140(4):355-7. Epub 2015 Sep 4.

From the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl);

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2015-0278-CPDOI Listing
April 2016

KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.

J Thorac Oncol 2016 Apr 30;11(4):496-503. Epub 2016 Jan 30.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.01.010DOI Listing
April 2016

MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression.

J Clin Oncol 2016 Mar 4;34(7):721-30. Epub 2016 Jan 4.

Mark M. Awad, Geoffrey R. Oxnard, David M. Jackman, Jennifer C. Heng, Suzanne E. Dahlberg, Pasi A. Jänne, and Peter S. Hammerman, Dana-Farber Cancer Institute; Mark M. Awad, Geoffrey R. Oxnard, David M. Jackman, Daniel O. Savukoski, Dimity Hall, Priyanka Shivdasani, Pasi A. Jänne, Peter S. Hammerman, and Lynette M. Sholl, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Suman Verma, ResearchDX, Irvine; and James Christensen, Mirati Therapeutics, San Diego, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.4600DOI Listing
March 2016

Targeted genomic sequencing of follicular dendritic cell sarcoma reveals recurrent alterations in NF-κB regulatory genes.

Mod Pathol 2016 Jan 13;29(1):67-74. Epub 2015 Nov 13.

Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2015.130DOI Listing
January 2016

Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung Cancer.

J Thorac Oncol 2015 Dec;10(12):1726-35

*Department of Medical Oncology, †Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; ‡Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts; §Harvard Medical School, Boston, Massachusetts; ‖Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts. ¶Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts; and #Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000687DOI Listing
December 2015

Clinical Implications of Variant ALK FISH Rearrangement Patterns.

J Thorac Oncol 2015 Nov;10(11):1648-52

*Brigham and Women's Hospital, Boston, Massachusetts; and †Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634010PMC
November 2015